Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026)

Varex Imaging's (VREX) quarterly Cash from Financing Activities came in at -$29.3 million in Q2 2026, down 4085.71% year-on-year from $735125.4 in Q2 2025, and down 1731.25% on a QoQ basis from -$1.6 million in Q1 2026.

Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026) Analysis & Trends

Varex Imaging (VREX) has 11 years of Cash from Financing Activities data on file, last reported at -$29.3 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 4085.71% year-over-year to -$29.3 million in Q2 2026; TTM through Apr 2026 was -$231.0 million, a 286.44% decrease from a year earlier, with the FY2025 full-year figure at -$75.9 million, down 2200.0% from the prior year.
  • Cash from Financing Activities for Q2 2026 stood at -$29.3 million, down from -$1.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for VREX reached as high as $124.9 million in Q1 2025 and fell as low as -$201.2 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged -$8.2 million across 5 years, with a median of -$700000.0 in 2023.
  • On a YoY basis, Cash from Financing Activities climbed as much as 7447.06% in 2025 and fell as far as 18190.91% in 2025.
  • Year by year, Cash from Financing Activities stood at -$400000.0 in 2022, then plunged by 325.0% to -$1.7 million in 2023, then soared by 147.06% to $800000.0 in 2024, then soared by 37.5% to $1.1 million in 2025, then slumped by 2763.64% to -$29.3 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$29.3 million in Q2 2026, -$1.6 million in Q1 2026, and $1.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Varex Imaging 450.24 Mn 375.84 Mn 72.60 Mn -29.30 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -29.30 Mn
Apr 3, 2026 -29.30 Mn
Jan 2, 2026 -1.60 Mn
Jan 2, 2026 -1.60 Mn
Oct 3, 2025 1.10 Mn
Oct 3, 2025 1.10 Mn
Jul 4, 2025 -201.20 Mn
Jul 4, 2025 -201.20 Mn
Apr 4, 2025 -700,000.00
Apr 4, 2025 -700,000.00
Jan 3, 2025 124.90 Mn
Jan 3, 2025 124.90 Mn
Sep 27, 2024 800,000.00
Sep 27, 2024 800,000.00
Jun 28, 2024 -1.10 Mn
Jun 28, 2024 -1.10 Mn
Mar 29, 2024 -1.30 Mn
Mar 29, 2024 -1.30 Mn
Dec 29, 2023 -1.70 Mn
Dec 29, 2023 -1.70 Mn